Literature DB >> 20306054

[Epidemiology of and preventive measures for multiresistant pathogens].

E-B Kruse1, M Dettenkofer.   

Abstract

Multidrug-resistant organisms (MROs) are increasing all over the world. The most important MROs are methicillin-resistant S. aureus, followed by vancomycin-resistant enterococci and extended-spectrum beta-lactamase (ESBL)-producing bacteria. The latter are not yet of much importance in ophthalmology. MROs can cause serious infections and must be considered in empiric therapy of nosocomial infections. To prevent further spread, standard and contact precautions have to be followed, and antibiotic stewardship needs to be introduced.

Entities:  

Mesh:

Year:  2010        PMID: 20306054     DOI: 10.1007/s00347-009-2074-2

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  45 in total

1.  Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units.

Authors:  Eli N Perencevich; David N Fisman; Marc Lipsitch; Anthony D Harris; J Glenn Morris; David L Smith
Journal:  Clin Infect Dis       Date:  2004-04-05       Impact factor: 9.079

2.  [MRSA and other multi-resistant pathogens: an ever increasing problem even in ambulant medicine].

Authors:  M Dettenkofer; A F Widmer; W V Kern
Journal:  Dtsch Med Wochenschr       Date:  2008-02       Impact factor: 0.628

Review 3.  Epidemiology, control and treatment of methicillin-resistant Staphylococcus aureus.

Authors:  G Peters; K Becker
Journal:  Drugs       Date:  1996       Impact factor: 9.546

4.  Stenotrophomonas maltophilia endophthalmitis after intraocular lens implantation.

Authors:  N Horio; M Horiguchi; K Murakami; E Yamamoto; Y Miyake
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2000-04       Impact factor: 3.117

Review 5.  Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat.

Authors:  Hajo Grundmann; Marta Aires-de-Sousa; John Boyce; Edine Tiemersma
Journal:  Lancet       Date:  2006-09-02       Impact factor: 79.321

6.  Epidemiological investigation after hospitalising a case with pandrug-resistant Acinetobacter baumannii infection.

Authors:  Y-Y Chuang; Y-C Huang; C-H Lin; L-H Su; C-T Wu
Journal:  J Hosp Infect       Date:  2009-03-12       Impact factor: 3.926

7.  Impact of contact and droplet precautions on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus infection.

Authors:  Ed Mangini; Sorana Segal-Maurer; Janice Burns; Annette Avicolli; Carl Urban; Noriel Mariano; Louise Grenner; Carl Rosenberg; James J Rahal
Journal:  Infect Control Hosp Epidemiol       Date:  2007-09-18       Impact factor: 3.254

Review 8.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

Review 9.  Mupirocin resistance.

Authors:  Jean B Patel; Rachel J Gorwitz; John A Jernigan
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

Review 10.  Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci.

Authors:  R Leclercq
Journal:  Clin Microbiol Infect       Date:  2009-03       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.